ArticlePloS one2016

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.

Pierre Gantner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.